Holen Sie sich die Stockscreener-App
71.90
0.77%
0.55
Handel nachbörslich:
71.86
-0.04
-0.06%
Boston Scientific Corp Aktie (BSX) Neueste Nachrichten
Bronstein, Gewirtz & Grossman LLC Urges Boston Scientific Corporation Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire Inc.
BSX DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026 - TMX Newsfile
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
Boston Scientific Investor Sues Over Growth Projections - Law360
Boston Scientific Overpromised Segment’s Performance, Suit Says - Bloomberg Law News
BSX Investors Have Opportunity to Lead Boston Scientific Corporation Securities Fraud Lawsuit - Barchart.com
BSX Stockholder Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Lawsuit Against Boston Scientific Corporation – Company AnnouncementFT.com - Financial Times
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Boston Scientific Corporation (BSX) - marketscreener.com
Rosen Law Firm Urges Boston Scientific Corporation (NYSE: BSX) Stockholders to Contact the Firm for Information About Their Rights - ChartMill
Boston Scientific’s ENTRUST Registry Targets Real-World Edge in Carotid Stroke Prevention - TipRanks
Why Is Boston Scientific (BSX) Down 6% Since Last Earnings Report? - Yahoo Finance
Boston Scientific to explain new ACC heart data to investors - Stock Titan
Boston Scientific to host investor event at the 75th Annual Scientific Session of the American College of Cardiology - Financial Times
Investor Notice: Robbins LLP Informs Investors of the Boston Scientific Corporation Class Action Lawsuit - The AI Journal
Boston Scientific (BSX) Advances While Market Declines: Some Information for Investors - Yahoo Finance
3 Reasons Boston Scientific Stock Could Quietly 5X as the World Ages - Nasdaq
April 24th Options Now Available For Boston Scientific (BSX) - Nasdaq
Boston Scientific (BSX) Raises Share Buyback Authorization To $5B - Finviz
Is It Time To Reconsider Boston Scientific (BSX) After The Recent Share Price Pullback - Yahoo Finance
Boston Scientific Target of Unusually Large Options Trading (NYSE:BSX) - MarketBeat
Boston Scientific : 3 ways we're reducing the environmental impact of our devices - marketscreener.com
Boston Scientific stock hits 52-week low at 72.63 USD - Investing.com South Africa
TD Cowen reiterates Boston Scientific stock rating on guidance confidence - Investing.com
Boston Scientific Corporation $BSX Shares Sold by Teachers Retirement System of The State of Kentucky - MarketBeat
BSX Earnings History & Surprises | EPS & Revenue Results | BOSTON SCIENTIFIC CORP (NYSE:BSX) - ChartMill
Boston Scientific: Near-Term EP Reset but 2027 Growth Drivers Support Buy Rating - TipRanks
1 Healthcare Stock to Target This Week and 2 Facing Challenges - Finviz
Penumbra Sale To Boston Scientific Puts Focus On Deal Terms And Future - simplywall.st
Boston Scientific (BSX) SVP converts RSUs, withholds 372 shares for taxes - Stock Titan
Boston Scientific (NYSE: BSX) Explains Rationale for Penumbra Deal - Stock Titan
Boston Scientific Corp Stock Moved Down by 3.32% on Mar 3: Facts Behind the Movement - TradingKey
Boston Scientific Corp. Experiences Evaluation Revision Amid Mixed Market Signals - Markets Mojo
Boston Scientific Corp.: Why This Quiet Medtech Giant Matters to You - AD HOC NEWS
Segall Bryant & Hamill LLC Has $23.51 Million Position in Boston Scientific Corporation $BSX - MarketBeat
The Zacks Analyst Blog Highlights Apple, TotalEnergies, Boston Scientific and Good Times Restaurants - Bitget
Boston Scientific gets Farapulse label expansion in Europe - Yahoo Finance
Boston Scientific Corp.: Why This Quiet Medtech Giant Is Suddenly On Watch - AD HOC NEWS
FDA recalls Boston Scientific stents, following three deaths, 160+ serious injuries - Worcester Business Journal
Boston Scientific wins expanded CE mark for Farapulse in persistent AFib - MassDevice
Boston Scientific Corporation (BSX) Stock Analysis: With a 36.3% Potential Upside, Is It Time to Invest? - DirectorsTalk Interviews
Andra AP fonden Buys 18,900 Shares of Boston Scientific Corporation $BSX - MarketBeat
111 Capital Makes New Investment in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific (BSX): Buy, Sell, or Hold Post Q4 Earnings? - Finviz
Levi & Korsinsky Investigates Possible Securities Fraud by Boston Scientific Corporation (BSX) - marketscreener.com
Austin InnoA huge medtech acquisition | Mental health startup launches subscription - The Business Journals
Vaginal Mesh Lawsuit Settlements | March 2026 Update - Lawsuit Information Center
TIAA Trust National Association Has $19.28 Million Stock Position in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corporation $BSX Stock Holdings Raised by Egerton Capital UK LLP - MarketBeat
American Century Companies Inc. Has $390.43 Million Stock Holdings in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific (BSX) Ascends While Market Falls: Some Facts to Note - Yahoo Finance
Boston Scientific (NYSE: BSX) EVP logs 6,851-share 401(k) rebalancing move - Stock Titan
Boston Scientific Corp. stock outperforms competitors on strong trading day - MarketWatch
Handelsbanken Fonder AB Sells 124,031 Shares of Boston Scientific Corporation $BSX - MarketBeat
R Squared Ltd Has $3.03 Million Holdings in Boston Scientific Corporation $BSX - MarketBeat
Argus Adjusts Price Target on Boston Scientific to $115 From $130, Maintains Buy Rating - marketscreener.com
Boston Scientific Corporation $BSX Holdings Lowered by Artisan Partners Limited Partnership - MarketBeat
Boston Scientific (BSX) Valuation Check After Strong Revenue Quarter And Buyback Expansion - simplywall.st
What Does the Street Think About Boston Scientific Corporation (BSX)? - Finviz
Boston Scientific Corp enters $3 billion revolving credit agreementSEC filing - marketscreener.com
Boston Scientific Wins Toss Of Spinal Device Suit - Law360
Boston Scientific Corporation Enter into A $3.000 Billion Revolving Credit Agreement - marketscreener.com
Boston Scientific (NYSE: BSX) lines up $11B to fund Penumbra deal - Stock Titan
Argus Lowers Boston Scientific Price Target to $115 From $130 - marketscreener.com
0.48%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):